PMID: 8472811Mar 1, 1993Paper

A retrospective analysis of bleeding complications in 438 patients with acute leukaemia during the years 1972-1991

European Journal of Haematology
E TörnebohmC Paul

Abstract

The incidence and mortality of bleeding complications have been investigated in 438 patients with acute leukaemia consolidated either by chemotherapy (n = 241) or by bone marrow transplantation (n = 197). Bleeding signs on admission were found in 38% of the chemotherapy-treated group. Haemorrhagic deaths during the 1st month were seen in 10%. The majority of the major bleedings were localized intracranial, but gastrointestinal haemorrhages were also common. The platelet count was significantly lower (40 x 10(9)/l versus 69 x 10(9)/l, p < 0.001) and the leukocyte count significantly higher (31.2 x 10(9)/l versus 11.6 x 10(9)/l, p < 0.001) in the group with bleeding complications than in those without. The haemorrhagic mortality in patients consolidated with chemotherapy compared with transplant patients was similar, 23% and 19%. The majority of the lethal haemorrhages in the latter group were observed in patients undergoing allogenic bone marrow transplantation after engraftment. Septicaemia, graft-versus-host and venous occlusive disease were contributing factors.

Citations

Jan 1, 1995·European Journal of Haematology·K E SletnesF Wisløff
Jan 1, 1995·Journal of Clinical Apheresis·R G Strauss
Oct 18, 2001·Current Opinion in Hematology·S Nevo, G B Vogelsang
Jul 20, 2007·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Ashish DixitRenu Saxena
Mar 13, 2001·Bone Marrow Transplantation·S NevoG B Vogelsang
Nov 26, 2010·Expert Review of Hematology·Hau C Kwaan, Timothy Huyck
May 24, 2019·American Journal of Hematology·Pernille Just VinholtChristian Nielsen
Feb 13, 2002·Bone Marrow Transplantation·L F Bleggi-TorresC R de Medeiros
Mar 27, 2004·Transfusion·Rachel KorethNigel S Key
Oct 5, 2010·The American Journal of Forensic Medicine and Pathology·Shangxun LiYiwu Zhou
Jan 13, 2021·Journal of Thrombosis and Haemostasis : JTH·Tzu-Fei WangJeffrey I Zwicker
Jan 28, 1999·Leukemia Research·E Archimbaud, X Thomas
Oct 26, 2005·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·A R SoyluH Simsek
Aug 2, 2007·Hematology/oncology Clinics of North America·Sherrill J Slichter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.